Our mission
INFRA is dedicated to transforming
the future of women's health
We are revolutionizing women's preventive health with a unique, AI-powered, holistic approach
Moving beyond reactive care, our technology delivers personalized, proactive insights to medical professionals, empowering women to stay ahead of potential issues

EARLY DETECTION OF BREAST CANCER
Changing the Natural History of Breast Cancer, Pushing the Limits of Early Detection
SOME BREAST CANCER FACTS
Breast cancer is the number one cancer in women, with a cancer diagnosed every 16 secs
Every 50 secs a woman dies from breast cancer
In 2022 over 2.3 million new breast cancer cases and 685,000 women died
From standard screening to Invisible image-based prediction
From current screening diagnostics to
personalized investigations
& Follow Up
Owning the disease
at its earliest stage
to improve
patient care of tomorrow

Interval Breast Cancer (IBC) detected between 2 screenings
​​
-
Before being visible on a mammogram, a breast cancer grows between 2 to 5 years
​
-
IBC represents 20 – 30% of all breast cancers cases
​
-
IBC are 6 times more likely to be grade III and 3.5 higher risk of breast cancer-related death.
Our mission : Anticipating IBC early detection
-
Early detection of breast cancer on normal mammograms is vital for anticipating interval cancers
​
-
Our AI solution identifies weak signals allowing for IBC prediction
​
-
INFRA provides an individual risk score to enable personalized follow-up strategies.
X​
.png)
Image generated by Gemini 2.0 ​​
.png)
Image generated by Gemini 2.0 ​​
How women will benefit from INFRA
-
Detecting breast cancer at the earliest stage
​
-
Reducing anxiety surrounding screening
​
-
Reducing the probability of invasive treatments
​
-
Increasing the chances of survival
They support INFRA's Mission
.png)
.png)
.png)
.png)
.png)
.png)
.png)
.png)